SYN-Tech Chem & Pharm Co Ltd
SYN-TECH Chem. & Pharm. Co., Ltd. manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally. The company offers test drugs and surfactants, as well as various Chinese, Western, and animal medicines. It also provides products in various categories, such as anticoagulant, attention deficit hyperactivity disorder, skeletal muscle relax… Read more
SYN-Tech Chem & Pharm Co Ltd (1777) - Total Liabilities
Latest total liabilities as of December 2025: NT$369.57 Million TWD
Based on the latest financial reports, SYN-Tech Chem & Pharm Co Ltd (1777) has total liabilities worth NT$369.57 Million TWD as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
SYN-Tech Chem & Pharm Co Ltd - Total Liabilities Trend (2015–2025)
This chart illustrates how SYN-Tech Chem & Pharm Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
SYN-Tech Chem & Pharm Co Ltd Competitors by Total Liabilities
The table below lists competitors of SYN-Tech Chem & Pharm Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Coxon Precise Industrial Co Ltd
TW:3607
|
Taiwan | NT$1.36 Billion |
|
Southern Rubber Industry JSC
VN:CSM
|
Vietnam | ₫2.45 Trillion |
|
SunWay Biotech Co., LTD.
TWO:1271
|
Taiwan | NT$939.36 Million |
|
Accuray Incorporated
NASDAQ:ARAY
|
USA | $394.59 Million |
|
IF Bancorp Inc
NASDAQ:IROQ
|
USA | $743.01 Million |
|
Multitude SE
LSE:0R4W
|
UK | €820.06 Million |
Liability Composition Analysis (2015–2025)
This chart breaks down SYN-Tech Chem & Pharm Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.03 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.14 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.12 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how SYN-Tech Chem & Pharm Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for SYN-Tech Chem & Pharm Co Ltd (2015–2025)
The table below shows the annual total liabilities of SYN-Tech Chem & Pharm Co Ltd from 2015 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | NT$369.57 Million | +26.72% |
| 2024-12-31 | NT$291.65 Million | -50.02% |
| 2023-12-31 | NT$583.48 Million | +0.58% |
| 2022-12-31 | NT$580.13 Million | -36.37% |
| 2021-12-31 | NT$911.71 Million | +68.38% |
| 2020-12-31 | NT$541.46 Million | -22.75% |
| 2019-12-31 | NT$700.89 Million | -3.44% |
| 2018-12-31 | NT$725.85 Million | +29.70% |
| 2017-12-31 | NT$559.62 Million | +115.30% |
| 2016-12-31 | NT$259.92 Million | +1.88% |
| 2015-12-31 | NT$255.12 Million | -- |